Osteosarcoma (OS) is the most common bone malignancy, and is particularly prevalent in
children and adolescents. OS is an aggressive tumor with a tendency to metastasize and …

Adipocyte enhancer‐binding protein 1 (AEBP1) is a transcriptional repressor involved in the
regulation of critical biological processes including adipogenesis, mammary gland …

Background: The development of heart failure (HF) remains a common complication
following an acute myocardial infarction (AMI), and is associated with substantial adverse …

Background Bladder cancer was a malignant disease in patients, our research aimed at
discovering the possible biomarkers for the diseases. Results The gene chip GSE31684 …

Cutaneous melanoma is very aggressive and results in high mortality rates for cancer
patients. Determining molecular targets is important for develo** novel therapies for …

Background Gliomas account for the majority of fatal primary brain tumors, and there is much
room for research in the underlying pathogenesis, the multistep progression of glioma, and …

Bladder cancer is a very common malignancy. Although new treatment strategies have been
developed, the identification of new therapeutic targets and reliable diagnostic/prognostic …

Simple Summary Bladder cancer is evidently a challenge as far as its prognosis and
treatment are concerned. The investigation of potential biomarkers and therapeutic targets is …

Osteoarthritis (OA) is a joint disease resulting in high rates of disability and low quality of life.
The initial site of OA (bone or cartilage) is uncertain. The aim of the current study was to …

Adipocyte enhancer binding protein 1 (AEBP1) is a transcriptional repressor that plays a
critical role in regulating adipogenesis. Recent studies have indicated that AEBP1 might …